BPC-157 2mg — Vial Spec, Reconstitution Math & COA

Overview of the BPC-157 2mg Vial Format

A 2mg vial of BPC-157 contains exactly 2,000 micrograms of high-purity, lyophilized Body Protection Compound 157, a synthetic pentadecapeptide derived from human gastric juice protein sequences. In preclinical laboratory settings, the 2mg unit mass is predominantly selected by investigators conducting low-volume bench assays, acute rodent injury models, or pilot dose-response trials. Because peptide stability begins to decline once dissolved in aqueous diluents, working with a 2mg mass allows research teams to prepare fresh working solutions for short-duration studies without risking compound degradation over extended storage periods.

While PX1 Research offers multiple configuration options across our primary target offerings—including standard 5mg vials available directly on the main BPC-157 product page—evaluating smaller unit sizes like 2mg provides distinct operational advantages for protocols requiring tight control over micro-dosing concentration. Investigators evaluating overall assay layout and inventory requirements can examine all available formats within our comprehensive catalog of research peptides.

Physicochemical Profile and Preclinical Research Targets

BPC-157 is categorized as a synthetically derived tissue repair peptide comprising 15 amino acids (Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val) with a molecular mass of approximately 1419.53 Da. In scientific literature, BPC-157 is primarily studied for accelerated repair of tendon, ligament, muscle, and gut lining tissues. These restorative properties are mediated via upregulated angiogenesis, enhanced focal adhesion kinase (FAK) and paxillin phosphorylation, and stimulated cellular migration directly to injured tissue sites.

Preclinical studies suggest that BPC-157 modulates vascular endothelial growth factor (VEGF) expression and nitric oxide (NO) synthesis pathways, promoting capillary sprouting in ischemic or damaged tissue matrices. In vitro assays using tenocytes, fibroblasts, and endothelial cell lines demonstrate accelerated cell scratch closure and enhanced extracellular matrix deposition upon exposure to stable BPC-157 concentrations. These cellular responses provide the mechanistic basis for ongoing investigations into soft tissue healing kinetics across animal models.

Reconstitution Mathematics for 2mg Lyophilized Vials

Calculating precise micro-concentrations prior to liquid handling is critical for achieving reproducibility across cell culture pipetting and animal model administration. When reconstituting a 2mg (2,000 mcg) cake of lyophilized peptide, the resulting concentration is inversely proportional to the volume of sterile diluent added (such as bacteriostatic water or sterile 0.9% sodium chloride).

To streamline volumetric planning at the laboratory bench, researchers should apply the following standard concentration ratios for a 2mg vial mass:

• 1.0 mL Diluent Addition: 2,000 mcg / 1.0 mL = 2,000 mcg/mL (or 2.0 mcg per microliter [µL]). Adding 10 µL yields 20 mcg of active peptide. • 2.0 mL Diluent Addition: 2,000 mcg / 2.0 mL = 1,000 mcg/mL (or 1.0 mcg per microliter [µL]). Adding 10 µL yields 10 mcg of active peptide. • 3.0 mL Diluent Addition: 2,000 mcg / 3.0 mL = 666.67 mcg/mL (or ~0.67 mcg per microliter [µL]). Adding 15 µL yields 10 mcg of active peptide.

For complex experimental designs or rapid conversion verification across custom diluent volumes, researchers can utilize our automated interactive reconstitution calculator to eliminate manual conversion error during experiment setup.

Aliquot Planning and Assay Pipetting Strategy

Repeated freeze-thaw cycles subject peptide chains to physical stress, leading to potential cleavage, aggregation, or surface adsorption to vial glass. To preserve structural integrity after liquid reconstitution of a 2mg BPC-157 vial, laboratory protocols should mandate immediate sub-aliquoting into single-use micro-centrifuge tubes.

Using low-binding polypropylene micro-centrifuge tubes prevents peptide loss via hydrophobic wall adhesion. Once the 2mg lyophilized cake is fully dissolved, aliquoting the solution into single-assay working volumes (e.g., 50 µL to 100 µL per tube) ensures that unmeasured portions remain frozen until their specific test iteration. Working solutions should be kept on ice during active laboratory pipetting and promptly returned to temperature-controlled storage.

Storage Parameters and Lyophilization Integrity

Lyophilized BPC-157 exhibits robust chemical stability when maintained under controlled ambient and sub-zero thermal conditions. Unreconstituted 2mg vials should be stored at -20°C in a desiccated, dark environment to prevent moisture absorption and hydrolytic degradation. Under these conditions, the cake retains analytical purity for extended periods up to 24 months.

Following reconstitution, liquid solutions are substantially more susceptible to temperature fluctuations and atmospheric oxidation. Reconstituted BPC-157 stored at 2°C to 8°C (standard laboratory refrigeration) should be utilized within 30 days. If extended liquid storage is necessary, aliquoted samples must be held at -20°C or -80°C. Researchers must avoid frost-free freezers, as their cyclic temperature fluctuation accelerates peptide denaturation.

Analytical Verification: Lot-Matched Certificates of Analysis (COA)

PX1 Research enforces rigorous quality control parameters to verify the chemical identity, purity profile, and biological safety of every production lot. Each batch undergoes independent testing at accredited ISO 17025 laboratories located in the USA. Analytical evaluation includes High-Performance Liquid Chromatography (HPLC) to establish purity metrics and Electrospray Ionization Mass Spectrometry (ESI-MS) to verify precise molecular weight.

Furthermore, every lot undergoes chromogenic Limulus Amebocyte Lysate (LAL) testing to confirm that bacterial endotoxin levels remain below strictly defined thresholds (<0.01 EU/mg), preventing confounding inflammatory responses in sensitive cell culture or animal assays. Principal investigators can review full analytical testing documentation and download verification reports directly from our transparent COA database.

Comparative Analysis: BPC-157 vs. Related Tissue Repair Compounds

In preclinical studies evaluating tissue regeneration mechanisms, BPC-157 is frequently compared with or evaluated alongside other specialized peptide sequences. While BPC-157 operates primarily by stimulating FAK pathways, VEGF expression, and cell migration in connective tissue and gut epithelium, synthetic GHK-Cu GHK-Cu acts predominantly as a copper-chelating signal peptide that modulates gene expression for collagen synthesis, decorin expression, and tissue remodeling. Similarly, TB-500 TB-500—a synthetic fragment of Thymosin Beta-4—drives actin-sequestering mechanisms that promote cell mobility and tissue repair across broader systemic pathways. In gastrointestinal inflammation models, researchers often contrast BPC-157 with the anti-inflammatory tripeptide KPV KPV, which targets nuclear factor kappa B (NF-κB) signaling directly in mucosal cells. Understanding these distinct mechanistic pathways assists laboratory teams in selecting the optimal compound or combination protocol for their specific research design.

Determining Optimal Mass Formats: 2mg vs. 5mg vs. 10mg Vials

Choosing between a 2mg vial and larger vial masses depends directly on the scale, duration, and dosing frequency of the experimental protocol. A 2mg vial mass is optimal for pilot studies, single-assay validation runs, or short-term rodent cohort testing where minimal reconstituted solution storage is desired. Utilizing smaller mass units limits reconstituted liquid shelf-life concerns and minimizes costly chemical waste.

Conversely, multi-week animal studies involving large rodent cohorts or daily treatment regimens benefit from larger unit masses, such as 5mg or 10mg vials, which simplify bulk solution preparation and lower unit material costs. For high-volume academic research institutions and institutional laboratories requiring scalable supply, PX1 Research provides volume-tiered options and institutional support through our dedicated wholesale program. Additional research insights and comparative scientific articles can also be reviewed within our central research hub.

Standard Operating Protocols for Laboratory Handling

To preserve the conformational structure of BPC-157 during liquid handling, laboratory personnel should adhere to standardized reconstitution protocols. Diluent should be introduced slowly along the inner glass wall of the vial using a sterile micro-syringe rather than squirted directly onto the lyophilized cake. Gentle side-to-side swirling should be applied to facilitate dissolution; mechanical agitation, vigorous shaking, or vortexing must be strictly avoided, as shear forces can induce peptide aggregation.

Aseptic technique must be maintained throughout the procedure. Reconstitution should occur inside a laminar flow hood, and vial stoppers should be sanitized with 70% isopropyl alcohol prior to needle insertion. Adherence to these strict operating parameters ensures assay reliability and prevents contamination of research samples.